Here are three points:
1. The INSPIRE study tests InVivo Therapeutics’ Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.
2. Neurosurgeon Stuart Lee, MD, serves as the site’s director.
3. Vidant Medical Center represents one of 22 U.S. and Canadian hospitals involved in the INSPIRE study.
More articles on devices:
Medline to build new distribution center; adds 100 jobs in Florida — 6 points
3D technology makes its mark in medical device industry — 3 observations
Spine Wave launches Velocity L Expandable Interbody Device & lateral system: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
